These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36125379)

  • 1. Pulmonary Dysfunction after Pediatric COVID-19.
    Heiss R; Tan L; Schmidt S; Regensburger AP; Ewert F; Mammadova D; Buehler A; Vogel-Claussen J; Voskrebenzev A; Rauh M; Rompel O; Nagel AM; Lévy S; Bickelhaupt S; May MS; Uder M; Metzler M; Trollmann R; Woelfle J; Wagner AL; Knieling F
    Radiology; 2023 Mar; 306(3):e221250. PubMed ID: 36125379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent
    Matheson AM; McIntosh MJ; Kooner HK; Lee J; Desaigoudar V; Bier E; Driehuys B; Svenningsen S; Santyr GE; Kirby M; Albert MS; Shepelytskyi Y; Grynko V; Ouriadov A; Abdelrazek M; Dhaliwal I; Nicholson JM; Parraga G
    Radiology; 2022 Nov; 305(2):466-476. PubMed ID: 35762891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Abnormalities Detected with Hyperpolarized
    Grist JT; Collier GJ; Walters H; Kim M; Chen M; Abu Eid G; Laws A; Matthews V; Jacob K; Cross S; Eves A; Durrant M; McIntyre A; Thompson R; Schulte RF; Raman B; Robbins PA; Wild JM; Fraser E; Gleeson F
    Radiology; 2022 Dec; 305(3):709-717. PubMed ID: 35608443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings.
    Li X; Wang H; Zhao R; Wang T; Zhu Y; Qian Y; Liu B; Yu Y; Han Y
    Radiology; 2021 May; 299(2):E230-E240. PubMed ID: 33434112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection.
    Cho JL; Villacreses R; Nagpal P; Guo J; Pezzulo AA; Thurman AL; Hamzeh NY; Blount RJ; Fortis S; Hoffman EA; Zabner J; Comellas AP
    Radiology; 2022 Jul; 304(1):185-192. PubMed ID: 35289657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-Breathing Low-Field MRI of the Lungs Detects Functional Alterations Associated With Persistent Symptoms After COVID-19 Infection.
    Lévy S; Heiss R; Grimm R; Grodzki D; Hadler D; Voskrebenzev A; Vogel-Claussen J; Fuchs F; Strauss R; Achenbach S; Hinsen M; Klett D; Schmid J; Kremer AE; Uder M; Nagel AM; Bickelhaupt S
    Invest Radiol; 2022 Nov; 57(11):742-751. PubMed ID: 35640012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary function in paediatric post-COVID-19: a controlled clinical trial.
    Schoeffl I; Raming R; Tratzky JP; Regensburger AP; Kraus C; Waellisch W; Trollmann R; Woelfle J; Dittrich S; Heiss R; Knieling F; Weigelt A
    Eur J Pediatr; 2024 Apr; 183(4):1645-1655. PubMed ID: 38193996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic imaging tests for the diagnosis of COVID-19.
    Islam N; Salameh JP; Leeflang MM; Hooft L; McGrath TA; van der Pol CB; Frank RA; Kazi S; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Wang J; McInnes MD;
    Cochrane Database Syst Rev; 2020 Nov; 11():CD013639. PubMed ID: 33242342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.